PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31325197-5	2019	Western blot analysis confirmed that delphinidin treatment can significantly decrease the expression of beta-catenin, glycogen synthase kinase-3beta (Gsk3beta), c-Myc, cyclin-D1, and matrix metalloproteinase-7(MMP-7) expression in breast cancer cells, and inhibition of miR-34a significantly reduced the effect of delphinidin on c-Myc, cyclin-D1, and MMP-7.	delphinidin	37-48	matrix metallopeptidase 7	Homo sapiens	183-209	
31325197-5	2019	Western blot analysis confirmed that delphinidin treatment can significantly decrease the expression of beta-catenin, glycogen synthase kinase-3beta (Gsk3beta), c-Myc, cyclin-D1, and matrix metalloproteinase-7(MMP-7) expression in breast cancer cells, and inhibition of miR-34a significantly reduced the effect of delphinidin on c-Myc, cyclin-D1, and MMP-7.	delphinidin	37-48	matrix metallopeptidase 7	Homo sapiens	210-215	
31325197-5	2019	Western blot analysis confirmed that delphinidin treatment can significantly decrease the expression of beta-catenin, glycogen synthase kinase-3beta (Gsk3beta), c-Myc, cyclin-D1, and matrix metalloproteinase-7(MMP-7) expression in breast cancer cells, and inhibition of miR-34a significantly reduced the effect of delphinidin on c-Myc, cyclin-D1, and MMP-7.	delphinidin	37-48	matrix metallopeptidase 7	Homo sapiens	351-356